In addition, it addresses the FDA’s communications While using the applicant, the retention of data that assistance the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may well transfer ownership of an SE report back to a new applicant and Digital submission from the SE report and